Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Nippon Indosari Corpindo Tbk. (ROTI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Nippon Indosari Corpindo Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp610 (market cap 3.74T, 353.4K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 6.5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 353.4K). Which is the better fit depends on your goals.

LABSROTI
Market Cap
576.7B3.74T
Volume
3.48M353.4K
Lot
34.82K3.53K
Turnover
522.79M216.64M
Average Price
150.13613.02
Value
522.79M216.64M
Indicative Equilibrium Price
148610
Indicative Equilibrium Volume
35095

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
ROTI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Nippon Indosari Corpindo Tbk.

PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on ROTI